ReportsnReports.com: Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value
GBI Research, the leading business intelligence provider, has released its latest research “Metabolic Disorders Therapeutics Market to 2017 – Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value”, which provides insights into metabolic disease therapeutics marled until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The report provides an in-depth analysis of the major metabolic diseases including Diabetes,...
View full press release